Dyadic International Inc. (DYAI)

Business: Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States.

IPO Date: 05-Nov-2004

Founder, CEO, Pres & Director: Mr. Mark A. Emalfarb

Chief Financial Officer: Ms. Ping Wang Rawson CPA, M.B.A.

Listing: NASDAQ: DYAI

Country: United States

Headquarters: Jupiter, FL

Website: https://www.dyadic.com

Market cap: $85.92 Mln

Revenue (TTM): $2.59 Mln

Earnings (TTM): $-12.27 Mln

Cash: $15.44 Mln

Total Debt: $0.00 Mln

Insider's Holding: 29.56%

Liquidity: Low

52 Week range: $1.74 - 6.89

Shares outstanding: 28,264,200

10 Years Aggregate:

• CFO: $-38.22 Mln
• EBITDA: $-53.94 Mln
• Net Profit: $18.59 Mln